AAAAAA
Results:
1-14
|
Results: 14
Authors:
Bear, HD
Roberts, J
Cornell, D
Tombes, MB
Kyle, B
Citation: Hd. Bear et al., Adoptive immunotherapy of cancer with pharmacologically activated lymph node lymphocytes: a pilot clinical trial, CANCER IMMU, 50(5), 2001, pp. 269-274
Authors:
Chin, CS
Graham, LJ
Hamad, GG
George, KR
Bear, HD
Citation: Cs. Chin et al., Bryostatin/ionomycin-activated T cells mediate regression of established tumors, J SURG RES, 98(2), 2001, pp. 108-115
Authors:
Latosinsky, S
Bear, HD
Citation: S. Latosinsky et Hd. Bear, Do surgical oncologists achieve lower rates of local-regional recurrence in node positive breast cancer treated with mastectomy alone?, J SURG ONC, 78(1), 2001, pp. 2-7
Authors:
Bear, HD
Citation: Hd. Bear, Guest editorial - Combination technique for sentinel node mapping in breast cancer, J SURG ONC, 77(1), 2001, pp. 6-7
Authors:
Tomaszewski, JE
Bear, HD
Connally, JA
Epstein, JI
Feldman, M
Foucar, K
Layfield, L
LiVolsi, V
Sirota, RL
Stoler, MH
Stombler, RE
Citation: Je. Tomaszewski et al., Consensus conference on second opinions in diagnostic anatomic pathology -Who, what, and when, AM J CLIN P, 114(3), 2000, pp. 329-335
Authors:
Kos, FJ
Cornell, DL
Lipke, AB
Graham, LJ
Bear, HD
Citation: Fj. Kos et al., Protective role of IL-2 during activation of T cells with bryostatin 1, INT J IMMUN, 22(8), 2000, pp. 645-652
Authors:
Latosinsky, S
Cornell, D
Bear, HD
Karp, SE
Little, S
De Paredes, E
Citation: S. Latosinsky et al., Evaluation of stereotactic core needle biopsy (SCNB) of the breast at a single institution, BREAST CANC, 60(3), 2000, pp. 277-283
Authors:
Bear, HD
Carter, WH
Grimes, MM
Citation: Hd. Bear et al., Despite limited data, coexistent lobular carcinoma in situ should not be acontraindication to breast conservation for women with invasive breast carcinoma, CANCER, 88(5), 2000, pp. 978-981
Authors:
Mamounas, E
Wieand, S
Wolmark, N
Bear, HD
Atkins, JN
Song, K
Jones, J
Rockette, H
Citation: E. Mamounas et al., Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' c colon cancer: Results from four national surgical adjuvant breast and bowel project adjuvant studies (C-01, C-02, C-03, and C-04), J CL ONCOL, 17(5), 1999, pp. 1349-1355
Authors:
Wolmark, N
Rockette, H
Mamounas, E
Jones, J
Wieand, S
Wickerham, DL
Bear, HD
Atkins, JN
Dimitrov, NV
Glass, AG
Fisher, ER
Fisher, B
Citation: N. Wolmark et al., Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: Results from national surgical adjuvant breast and bowel project C-04, J CL ONCOL, 17(11), 1999, pp. 3553-3559
Authors:
Schweitzer, S
Hogge, JP
Grimes, M
Bear, HD
de Paredes, ES
Citation: S. Schweitzer et al., Cowden disease: A cutaneous marker for increased risk of breast cancer, AM J ROENTG, 172(2), 1999, pp. 349-351
Authors:
Arthur, DW
Schmidt-Ullrich, RK
Friedman, RB
Wazer, DE
Kachnic, LA
Amir, C
Bear, HD
Hackney, MH
Smith, TJ
Lawrence, W
Citation: Dw. Arthur et al., Accelerated superfractionated radiotherapy for inflammatory breast carcinoma: Complete response predicts outcome and allows for breast conservation, INT J RAD O, 44(2), 1999, pp. 289-296
Authors:
Bear, HD
Citation: Hd. Bear, Another view of the Tamoxifen Trial - Commentary, J SURG ONC, 72(1), 1999, pp. 6-8
Authors:
Bear, HD
Citation: Hd. Bear, Melanoma, CANCER SURGERY FOR THE GENERAL SURGEON, 1999, pp. 137-154
Risultati:
1-14
|